FDA Warning Letter — Exxon

Case 605942 — FEI 3015256205

The FDA took a Warning Letter action against Exxon on Apr 2, 2020 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Exxon
Date
Apr 2, 2020
Fiscal Year
2020
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.